X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
Other Suppliers
0
USA (Orange Book)
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
https://www.ema.europa.eu/en/documents/overview/pretomanid-fgk-epar-medicine-overview_en.pdf
https://endpts.com/ayahuasca-inspires-another-biotech-startup-at-atai-mylan-tb-drug-gets-green-light-in-india/
https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-23-26-march-2020
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/tb-alliance-seeks-clinical-trial-waiver-for-pretomanid-drug/articleshow/71849956.cms
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/mylan-working-with-dcgi-to-launch-new-tb-drug-in-india/articleshow/71596132.cms
https://economictimes.indiatimes.com/industry/healthcare/biotech/healthcare/new-treatment-to-be-made-affordable-for-patients-tb-alliance/articleshow/70887095.cms
https://www.prnewswire.com/news-releases/fda-approves-new-treatment-for-highly-drug-resistant-forms-of-tuberculosis-300901801.html
https://www.reuters.com/article/us-tb-alliance-fda/fda-advisory-panel-recommends-approval-of-tb-alliances-tuberculosis-treatment-idUSKCN1T72QP
Market Place
Share 
